# Dobutamine Hydrochloride Injection: FDA shortage status

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: current
- Source statuses: Current, To Be Discontinued
- FDA package records: 11
- Latest FDA row update: 08/27/2025
- Retrieved: 2026-08-22T15:54:11+00:00

## FDA package and manufacturer records

- Baxter Healthcare — Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02) — FDA availability: Available — updated: 08/17/2026
- Baxter Healthcare — Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02) — FDA availability: Available — updated: 08/17/2026
- Baxter Healthcare — Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02) — FDA availability: Available — updated: 08/17/2026
- Hainan Poly Pharm. Co., Ltd. — Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80) — FDA availability: Available — updated: 05/08/2026
- Hospira, Inc., a Pfizer Company — Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (400 mg/mL) (NDC 0409-3724-32) — FDA availability: Available — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (100 mg/mL) (NDC 0409-2346-32) — FDA availability: Available — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (200 mg/mL) (NDC 0409-2347-32) — FDA availability: Available — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01) — FDA availability: Available — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02) — FDA availability: Available — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88) — FDA availability: Unavailable — updated: 08/07/2026
- Pfizer Inc. — Dobutamine Hydrochloride, Injection, 12.5 mg/1 mL (NDC 0409-2344-88) — FDA availability: Not stated — updated: 08/27/2025

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/dobutamine-hydrochloride-injection)
- [JSON record](https://citefacts.com/shortages/dobutamine-hydrochloride-injection.json)